Summary. We studied the composition of tissue-bound immunoglobulins and of antinuclear factors by immunofluorescent techniques in five patients with systemic lupus and two with chronic liver disease associated with positive LE cell tests. Renal glomeruli in all seven demonstrated deposits of bound yG-globulin and complement, although the presence of -yA-and yMimmunoglobulins was variable. Blood vessel walls contained primarily yGglobulin and complement in the systemic lupus patients, but such deposits were absent from vessels in the two with chronic liver disease.
Introduction
The participation of an immune mechanism in the pathogenesis of systemic lupus erythematosus has been suggested by the presence of tissuebound immunoglobulins and complement in renal glomeruli and blood vessels (1) (2) (3) (4) (5) (6) (7) and diminution of serum complement during the acute phase of disease (8) (9) (10) . Antibodies to nucleoprotein and to DNA have been found in higher titer during the acute phase of SLE than during periods of remission (10) (11) (12) , especially in association with a low serum complement level. A direct cytotoxic role for antinuclear factors has seemed unlikely, since transfusion of these factors into healthy recipients has not induced disease and introduction of such serologic factors into tissue cultures has not affected cell viability (13, 14) . Morphologic studies have revealed that the immunoglobulin and electron-dense deposits in lupus glomeruli exhibit a granular or nodular appearance, which resembles that of deposits of antigenantibody complexes in experimental serum sickness (15) . Freedman and Markowitz (16) have reported that y-globulin eluted from glomeruli of a lupus kidney was reactive with cell nuclei in the presence of fresh human serum. These observations have directed attention to possible derivation of tissue-bound immunoglobulins from antinuclear factors present as constituents of deposited antigen-antibody complexes or as antibodies reactive with fixed tissue antigens. In certain forms of chronic liver disease, antinuclear factors including the LE cell factor are present in the serum. The relationship between systemic lupus and liver disease associated with autoimmune serologic phenomena remains unclear. Furthermore, the varied clinical and histopathologic findings in such forms of chronic liver disease have made the definition of lupoid hepatitis as a nosologic entity difficult (17) (18) (19) .
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In the present report, the postmortem tissues of five patients with systemic lupus and two with chronic liver disease associated with positive LE cell tests were studied for the distribution of the tissue-bound immunoglobulins and complement. The immunoglobulin composition of these tissue deposits in renal glomeruli was found to correlate with the immunoglobulin classes or antinuclear factors (20) in the sera of these patients.
In experiments reported in a subsequent paper (21) high dosage steroid therapy showed maximal nuclear reactivity and were selected for this study. Twofold serum dilutions were tested for yG, yM, and yA antinuclear factors with normal human spleen and liver sections. The tissue sections were exposed for 1 hour to each dilution of serum, washed for 10 minutes in buffered saline, exposed for 1 hour to fluorescein-conjugated specific antiimmunoglobulin sera, and finally mounted in glycerolbuffer. The highest serum dilution that permitted nuclear staining was taken as the titer of the immunoglobulin antinuclear activity.
We prepared antiserum against -yG-globulin isolated by DEAE-cellulose cess with yG-and jiM-globulins, respectively, showed complete removal of immunofluorescent staining properties. The jG was isolated by DEAE-cellulose chromatography (22) . The jiM,3 a cryoglobulin, was separated from a redissolved 7 S-19 S cryoprecipitate on a Sephadex G-200 column.
All antisera and fluorescent conjugates were absorbed with mouse organ powder before use. The rabbit antigoat conjugate was further absorbed with lyophilized normal human serum.
We obtained rabbit antiserum 4 specific for the 8sc component of C'3 of human complement (23) . Specificity of antiserum for j8ic was demonstrated by the suppression of staining after absorption of the antiserum with fractions of C'3 containing fl1C.5 Goat antirabbit globulin conjugate was employed with the pc antiserum in the indirect fluorescent antibody method. Fluorescent microscopy was performed with an American Optical microscope used with an Osram HBO 200-w mercury lamp and fitted with a UG-2 exciter filter and Wratten 2A barrier filter.
Latex FII agglutination was performed by the modified method of Singer, Altmann, Goldenberg, and Plotz with glycine-saline buffer, pH 8.2, as diluent (24) . LE cell preparations were made by the method of Zinkham and Conley (25) . Anti-DNA activity was tested by bentonite flocculation without the addition of methylene blue (26 
Results
Immunoglobulins and complement in renal glomeruli. Clinical data for the seven patients are shown in Table I , and histopathologic findings are summarized in Table II .
In all five systemic lupus patients, renal glomeruli showed extensive deposits of yG-globulin diffusely present in capillary loops in a granular or nodular distribution (Figures 1, left, and 2 , left). Occasionally, yG-globulin was observed in Bowman's capsule. In addition to yG, yMglobulin was detected in renal glomeruli of one lupus patient (FP) in focal nodular deposits. yAGlobulin was observed in glomeruli of three systemic lupus patients (1, 2, and 4) and showed diffuse linear staining of capillary loops with deposits also in Bowman's capsule at sites of adhesions (Figure 1, right) . In the two patients with chronic liver disease, nodular deposits of yG and yM were present in renal glomeruli ( Figure  3 , top and center), but yA was not identified. In all seven patients, localization of complement flic paralleled the pattern of distribution of yG deposits (Figures 2, right, and 3, bottom) . The distribution of specific immunoglobulins and complement in renal glomeruli is summarized in Table  III. Tubular casts frequently showed intense staining for yG-globulin. In four patients (1-4), segments of tubular epithelium showed deposits of Immunoglobulins and complement in vessel walls. Diffuse vasculitis with fibrinoid change was present in all five of the systemic lupus patients, whereas blood vessels in the two with liver disease showed only minimal intimal thickening (Table II) .
In parallel with these histopathologic observations, yG-globulin and complement were found in vessel walls in organs of the five lupus patients, but no deposits were noted in vessels in tissues of those with chronic liver disease (Table III) Table IV. Localization of yG-globulin and complement in arteries was predominantly in the media with appreciably less intense staining in intima and adventitia. In veins, the deposits were concentrated in both intima and media and were granular (Figure 4, top Correlations between tissue-bound immunoglobulins and immunoglobulin classes of antinuclear factors. In the five systemic lupus patients and the two with chronic liver disease, antinuclear factors occurred in all three immunoglobulin classes, as shown in Table IV and Figure 5 . Because of differences in the sensitivities of the methods of detection inherent in the immunofluorescent technique, only the antinuclear factor titers within a given class of immunoglobulins may be directly compared.
In all seven patients, yG-globulin was the major constituent of renal deposits, and yG antinuclear activity was present at serum dilutions up to 1/256. In Patients 1, 2, and 4, yA-globulin was also present in renal glomeruli and was associated with yA antinuclear factors at serum dilutions of 1/8 to 1/16. These titers of reac- t yA-Globulin was also present.
--yG-Globulin and complement were also absent from vessels in esophagus, brain, adrenal, and pancreas. A similar correlation between immunoglobulins in blood vessels and immunoglobulin class of antinuclear factors was demonstrated in the lupus patients. The presence of yG-globulin in blood vessels was associated with elevated yG antinuclear factor titers. The additional presence of yA in vessels of Patient 2 was accompanied by elevated yA antinuclear activity detected at a serum titer of 1/16.
Examination of patterns of nuclear reactivity in the lupus patients indicated that yG-globulin factors showed homogeneous, shaggy, speckled, and peripheral staining. yM and yA factors gave homogeneous and peripheral staining, with the latter appearing particularly prominent ( Figure 6 , top and bottom). In the liver disease patients, nuclear reactive patterns were similar to those observed in the systemic lupus patients, except for the absence of the shaggy pattern.
Anti-DNA activity, determined by bentonite flocculation, was present in four of the five systemic lupus patients but in neither of the chronic liver disease patients. Although rheumatoid factor was also present in the sera of two of the three patients with yM antinuclear factors, the specific binding of yM-globulin in these sera with nuclear antigen was demonstrated by the persistence of reactivity after absorption of sera with aggregated human serum Fraction II. Furthermore, it could not be demonstrated that the -yM-globulin deposits in the glomeruli of Patient 7 were related to bound rheumatoid factor, since no reaction was obtained by staining this kidney with aggregated fluorescent human y-globulin ( Fraction II). Relative immunoglobulin levels in the serum, determined by titration against standard reference specific antisera, showed no correlation with the presence of tissue-bound immunoglobulins or the immunoglobulin class of antinuclear factors (Table IV) .
Tests of sera of all seven patients against autologous or homologous kidney sections gave no evidence of serologic reactivity with glomerular or vascular structures other than nuclei. Similarly, no serologic reaction could be demonstrated by immunofluorescence with autologous or homologous liver constituents, including hepatic parenchyma, biliary ducts, and vessel walls.
Discussion
In experimental models of renal disease in animals, immunofluorescent data have indicated that bound y-globulin related to immune injury is dis-tributed in a diffuse glomerular capillary loop pattern and exhibits a variable morphologic appearance characteristic of the model under study. Thus, in experimental serum sickness in the rabbit, host y-globulin is distributed in granular or lumpy aggregates ascribed to deposited antigenantibody complexes (27, 15) . In the model of nephrotoxic nephritis, the uninterrupted linear fluorescence of y-globulin observed in glomerular basement membrane is attributable to antibody fixed to antigen or antigens in this structure (28, 29) .
As described in the present work, the glomerular staining of immunoglobulins was most commonly noted as discrete focal nodular deposits throughout segments of capillary loops. Occasionally, e.g., with yA-globulin deposits, a continuious linear reaction with basement membrane was also noted. The granular and focal nodular deposits were suggestive of deposition of circulating antigen-antibody complexes, as observed in experimental models, although the instances of segmental staining of glomerular membrane were also consistent with a possible immune reaction with a fixed renal antigen. The distribution of tissue-bound immunoglobulins and complement in systemic lupus has also recently been described by Paronetto and Koffler (5) , who also noted beaded staining in a diffuse distribution for all three immunoglobulins in glomerular capillary loops.
The deposits of yG-globulin and complement in vessel walls often showed a granular or amorphous appearance within segments of media. The morphology of the staining reaction closely resembled that attributable to deposits of antigen-antibody complexes in experimental serum sickness arteritis (30) .
The possibility that circulating complexes derived specifically from antinuclear factors and nuclear antigens may be related to deposition of yglobulin in kidney and vessels in systemic lupus has been suggested by the following lines of evidence. Clinical activity and the presence of renal disease have been correlated with elevated titers of anti-DNA and antinucleoprotein with decreased levels of sertum complement (8) (9) (10) (11) (12) . The presence of antinuclear activity in eluates of isolated glomeruli from a lupus kidney has been described by Freedman and Markowitz (16) . Tan, Schur, and Kunkel (31) have reported, in a patient with lupus nephritis, occurrence of circulating DNA with acute febrile episodes and increased proteinuria and have suggested that formation of DNA-anti-DNA complexes may be related to renal injury. The present work lends further support to the possible derivation of immunoglobulin deposits in glomeruli and vessel walls from antinuclear immunoglobulins, since the presence of a tissue-bound immunoglobulin was commonly associated with an elevated antinuclear titer of the same immunoglobulin class. Although this association is probably best interpreted in the context of deposited immune complexes, an alternative hypothesis is that the deposited immunoglobulins could be derived from circulating antinuclear factors of abnormal physicochemical properties and diminished solubility, perhaps analogous to single or multiple component cryoglobulins (32) . Cryoglobulins, or cryoprecipitates containing immunoglobulins and complement, have been observed with variable frequency in sera of patients with lupus nephritis (33, 34) . It has been suggested that these may be derived from circulating complexes, although an association with DNA or DNA-protein has been noted only rarely (34) . Antinuclear activity has been found to be associated with such cryoglobulins in the absence of detectable DNA or -DNA-protein by Barnett, Goldberg, and Tishkoff (35) as well as in this laboratory (36) .
The converse finding that elevated antinuclear factor activity was not invariably associated with deposits of the same immunoglobulin in renal glomeruli also merits comment. Evidence has been presented by Barnett and Vaughan (37) of presence in low concentration of antigenic nuclear material, including DNA, in normal human sera, whereas Tan and co-workers (31) and Barnett (38) In the lupus patients, the immunoglobulin composition of deposits in blood vessel walls was limited to -yG-globulin and, in one, yA-globulin, in contrast to presence in glomerular deposits of yM-globulin also. The basis of this variation is unexplained. It could perhaps be related to differing rates of entrapment of macromolecular or immune complexes in glomeruli compared to blood vessels, to differences of endothelial permeability, or to differences of hemodynamic factors in the two sites. It is of interest, from the point of view of comparative immunopathology, that no immunoglobulin deposits were found in vessel walls in the two patients with chronic liver disease, in contrast to the findings in the glomeruli. The absence of vasculitis and fibrinoid change has been previously reported in lupoid hepatitis (19, 39, 40) . In the present study, the failure to detect bound immunoglobulins and complement in blood vessels in the liver disease patients together with the absence of anti-DNA are in contrast to the findings in the systemic lupus patients and perhaps direct attention to a possible relationship of anti-DNA to vascular disease in lupus.
No deposits of immunoglobulins or complement in liver or reactivity of sera for components of autologous or homologous liver was demonstrated in the two chronic liver disease patients or in the two with systemic lupus with histopathologic evidence of liver disease. Gajdusek (41) described antibodies to the aqueous extracts of normal human liver in sera from patients with diverse liver diseases including lupoid hepatitis, but these antibodies were not organ specific. Taft, Mackay, and Larkin (42) reported that sera from a lupoid hepatitis patient contained complement-fixing antibodies that were more reactive with autologous tissues than with homologous normal tissues, but no correlation was observed with respect to antibody titer, tissue specificity of reactive antigen, and clinical activity. It may be speculated that the postulated hepatotoxic antibodies are present in sera in concentrations too low for detection by current immunofluorescent procedures. Alternatively, either the "antibodies" may be cellular in nature, or this form of liver injury may be entirely unrelated to immune mechanisms.
